Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ACCUPROBE BLASTOMYCES DERMATIT CULT CONFIRM TEST

K-Number: K903201 · 1990-09-12

ApplicantGen-Probe, Inc.
Decision Date1990-09-12
Product CodeMDC
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

ACCUPROBE BLASTOMYCES DERMATIT CULT CONFIRM TEST is the device name listed in this FDA 510(k) record. The listed applicant is Gen-Probe, Inc.. It received FDA 510(k) clearance on 1990-09-12 under 510(k) number K903201. The device is classified under product code MDC. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ACCUPROBE BLASTOMYCES DERMATIT CULT CONFIRM TEST?

ACCUPROBE BLASTOMYCES DERMATIT CULT CONFIRM TEST is a medical device that received FDA 510(k) clearance on 1990-09-12. The listed applicant is Gen-Probe, Inc.. The 510(k) number is K903201.

When did ACCUPROBE BLASTOMYCES DERMATIT CULT CONFIRM TEST receive FDA 510(k) clearance?

ACCUPROBE BLASTOMYCES DERMATIT CULT CONFIRM TEST received FDA 510(k) clearance on 1990-09-12, under 510(k) number K903201.

Who is the listed applicant for ACCUPROBE BLASTOMYCES DERMATIT CULT CONFIRM TEST?

The FDA 510(k) record lists Gen-Probe, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ACCUPROBE BLASTOMYCES DERMATIT CULT CONFIRM TEST?

The FDA product code for ACCUPROBE BLASTOMYCES DERMATIT CULT CONFIRM TEST is MDC.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Gen-Probe, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K122062APTIMA TRICHOMONAS VAGINALIS ASSAY - PANTHERK111409APTIMA COMBO 2 ASSAYK063664GEN-PROBE APTIMA ASSAY FOR NEISSERIA GONORRHOEAE MODEL#1091K063451GEN-PROBE APTIMA ASSAY FOR CHLAMYDIA TRACHOMATIS, MODEL 1199K062440GEN-PROBE APTIMA ASSAY FOR NEISSERIA GONORRHOEAE, MODEL 1091K061413APTIMA CT ASSAY ON THE TIGRIS DTS SYSTEM

View all 62 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑